Qiyi Yi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Dna Methylation

Signaling Pathway

Top Venues

Cellular & molecular biology letters

Cell death discovery

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiyang Hou, Tianxiang Yu, Qiyi Yi, Yan Du, Libin Zhou, Ye Zhao, Yuejin Wu, Lijun Wu, Ting Wang, Po Bian
High-complexity of DNA double-strand breaks is key for alternative end-joining choice. Communications biology 7 (1) (2024)
Zhiyang Hou, Tianxiang Yu, Qiyi Yi, Yan Du, Libin Zhou, Ye Zhao, Yuejin Wu, Lijun Wu, Ting Wang, Po Bian
High-complexity of DNA double-strand breaks is key for alternative end-joining choice. Communications biology 7 (1) (2024)
Lei Lv, Qinqin Wei, Jianxiao Zhang, Yitong Dong, Zhenglei Shan, Na Chang, Ye Zhao, Po Bian, Qiyi Yi
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. Cellular & molecular biology letters 29 (1) (2024)
Lei Lv, Qinqin Wei, Jianxiao Zhang, Yitong Dong, Zhenglei Shan, Na Chang, Ye Zhao, Po Bian, Qiyi Yi
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. Cellular & molecular biology letters 29 (1) (2024)
Lei Lv, Qinqin Wei, Jianxiao Zhang, Yitong Dong, Zhenglei Shan, Na Chang, Ye Zhao, Po Bian, Qiyi Yi
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. Cellular & molecular biology letters 29 (1) (2024)
Qiyi Yi, Yujia Zhao, Ran Xia, Qinqin Wei, Fengmei Chao, Rui Zhang, Po Bian, Lei Lv
TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell death discovery 9 (1) (2023)
Fengmei Chao, Yang Zhang, Lei Lv, Yaqin Wei, Xiaoyan Dou, Na Chang, Qiyi Yi, Ming Li
Extracellular Vesicles Derived circSH3PXD2A Inhibits Chemoresistance of Small Cell Lung Cancer by miR-375-3p/YAP1. International journal of nanomedicine 18 (2023)
Qiyi Yi, Yujia Zhao, Ran Xia, Qinqin Wei, Fengmei Chao, Rui Zhang, Po Bian, Lei Lv
TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell death discovery 9 (1) (2023)
Wulin Shan, Chunyang Dai, Huanhuan Zhang, Dan Han, Qiyi Yi, Bairong Xia
ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway. Cancers 14 (22) (2022)
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors. Cancers 14 (23) (2022)
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors. Cancers 14 (23) (2022)
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors. Cancers 14 (23) (2022)
Tian Tian, Fu Hong, Zhiwen Wang, Jiaru Hu, Ni Chen, Lei Lv, Qiyi Yi
HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma. Cell death discovery 7 (1) (2021)
Lei Lv, Yujia Zhao, Qinqin Wei, Ye Zhao, Qiyi Yi
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma. Cancer cell international 20 (2020)